清醒内镜下上气道刺激装置的重新配置
术后平均AHI从40.6降至4.2,88%患者达到Sher治疗成功标准;19例(32%)患者因不适、频繁觉醒等原因接受了24次AE,首次AE后功能阈值和最小治疗幅度分别降低0.87 V(53%)和0.93 V(45%)。
要点
- UAS术后88%患者达到Sher治疗成功标准,平均AHI降低36.4。
- 约32%患者需清醒内镜重新配置装置,常见原因为刺激不适和频繁觉醒。
- 清醒内镜下调功能阈值和最小治疗幅度可能改善舒适度与依从性。
核心结论
- UAS治疗阻塞性睡眠呼吸暂停持续有效,不足三分之一患者需清醒内镜重新配置装置以优化设置。
- 清醒内镜后功能阈值和最小治疗幅度降低可能通过减少不适和频繁觉醒改善依从性。
- 植入UAS装置的患者需定期监测以优化疗效并维持依从性。
主要发现
- 术前和术后总AHI平均值分别为40.6和4.2,总AHI降低36.4。
- 基于Sher标准的治疗成功率为88%。
- 术后滴定多导睡眠图显示平均功能阈值(FT)和最小治疗幅度(MTA)分别为1.6 V和2.1 V。
- 19例(32%)患者共进行24次清醒内镜,最常见主诉为刺激不适(42%)、频繁觉醒(32%)和持续疲劳或AHI未正常化(21%)。
- 首次清醒内镜后,FT和MTA分别降低0.87 V(53%)和0.93 V(45%)。
关键数值与推荐
- 治疗成功基于Sher标准,88%患者达到。
- 术后滴定多导睡眠图平均FT为1.6 V,平均MTA为2.1 V。
- 首次AE后FT降低0.87 V(53%),MTA降低0.93 V(45%)。
临床怎么用
- 对UAS术后出现刺激不适、频繁觉醒或持续疲劳/AHI未正常化的患者,可考虑诊室清醒内镜评估咽部气道并重新配置装置。
- 清醒内镜下调整装置可能降低FT和MTA,从而改善舒适度和依从性。
- UAS植入患者应定期监测以优化疗效和维持依从性。
局限性
- 回顾性 chart review 设计,证据等级为4。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Determine the rates of, reasons for, and effectiveness of device reprogramming utilizing in-office awake endoscopy (AE) in subjects who underwent upper airway stimulation (UAS) surgery. STUDY DESIGN: Retrospective chart review. METHODS: Retrospective chart review at a tertiary care center on patients implanted with UAS devices from November 2015 to July 2018. RESULTS: Sixty patients were implanted with UAS devices. Average pre- and postsurgical total apnea-hypopnea index (AHI) was 40.6 and 4.2 with a 36.4 total AHI reduction. Treatment success based on Sher criteria was observed in 88% of patients. Postoperative titration polysomnography revealed an average functional threshold (FT) and minimum therapeutic amplitude (MTA) of 1.6 and 2.1 V, respectively. A total of 24 AEs were performed in 19 (32%) patients. The most common complaints and reasons for AE were perceived stimulus discomfort (42%), frequent awakenings (32%), and persistent fatigue or non-normalized AHI (21%). After first AE, there was a 0.87 (53%) and 0.93 (45%) V reduction in FT and MTA, respectively. CONCLUSION: Patients with obstructive sleep apnea continue to succeed with UAS. Fewer than one-third of patients had postsurgical complaints requiring device reconfiguration utilizing AE to assess the pharyngeal airway and optimize device settings. Reduction in the FT and MTA after AE may improve compliance by reducing discomfort and frequent awakenings. Periodic monitoring of patients with implanted UAS devices is necessary to optimize efficacy and maintain patient compliance. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:2494-2498, 2020.
引用
- Meleca JB, Kominsky AH. Reconfiguration of Upper Airway Stimulation Devices Utilizing Awake Endoscopy. Laryngoscope. 2020. PMID: 32096882. doi:10.1002/lary.28569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。